Share on StockTwits

Cytosorbents Corp (NASDAQ:CTSO) Director Al Kraus sold 50,000 shares of the stock in a transaction dated Thursday, July 10th. The shares were sold at an average price of $0.24, for a total transaction of $12,000.00. Following the sale, the director now directly owns 1,393,631 shares in the company, valued at approximately $334,471. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Cytosorbents Corp (NASDAQ:CTSO) traded down 2.08% during mid-day trading on Tuesday, hitting $0.235. The stock had a trading volume of 39,827 shares. Cytosorbents Corp has a 1-year low of $0.08 and a 1-year high of $0.35. The stock’s 50-day moving average is $0.24 and its 200-day moving average is $0.2. The company’s market cap is $70.3 million.

Separately, analysts at Zacks reiterated an “outperform” rating on shares of Cytosorbents Corp in a research note on Friday, May 16th. They now have a $0.50 price target on the stock.

CytoSorbents Corporation is a development stage critical care focused company using blood purification to treat life-threatening illnesses.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.